Gene expression profiles of poor-prognosis primary breast cancer correlate with survival.
暂无分享,去创建一个
E. Devilard | F. Bertucci | B. Loriod | A. Giaconia | S. Granjeaud | C. Nguyen | D. Birnbaum | R. Houlgatte | R. Tagett | P. Viens | V. Nasser | J. Jacquemier | J. Adélaı̈de | A. Benziane | F. Eisinger | Aurélia Giaconia
[1] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] T Tanaka,et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. , 2001, Cancer research.
[5] K. Furge,et al. Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Ethier,et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. , 2001, Cancer research.
[7] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[8] J. Styles,et al. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance , 2001, Oncogene.
[9] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Swain,et al. Update on adjuvant chemotherapy for early breast cancer. , 2000, Oncology.
[11] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[12] Eric S. Lander,et al. Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.
[13] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[14] M J O'Hare,et al. Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.
[15] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[16] Stuart A. Aaronson,et al. Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression , 2000, Molecular and Cellular Biology.
[17] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[18] C. Clevenger,et al. Prolactin as a chemoattractant for human breast carcinoma. , 1999, Endocrinology.
[19] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[20] C. Osborne,et al. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] F. Bertucci,et al. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. , 1999, Human molecular genetics.
[22] F. Bertucci,et al. Expression profiling: DNA arrays in many guises. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[23] Samuel Granjeaud,et al. Expression scanning of an array of growth control genes in human tumor cell lines , 1999, Oncogene.
[24] R. Weigel,et al. GATA‐3 is expressed in association with estrogen receptor in breast cancer , 1999, International journal of cancer.
[25] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[27] R. Colomer,et al. Angiogenin expression and prognosis in primary breast carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[29] J. Foekens,et al. Prognostic significance of cathepsins B and L in primary human breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] B. Trock,et al. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. , 1997, Journal of the National Cancer Institute.
[31] K. Osteen,et al. Regulation and localization of cellular retinol-binding protein, retinol-binding protein, cellular retinoic acid-binding protein (CRABP), and CRABP II in the uterus of the pseudopregnant rat. , 1996, Endocrinology.
[32] C. Der,et al. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. , 1996, Oncogene.
[33] W. Hiddemann,et al. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] Daniel Metzger,et al. Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.
[35] Walsh,et al. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. , 1995, Human pathology.
[36] P. Steeg,et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. , 1994, Cancer research.
[37] H. Chiba,et al. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. , 1994, Nucleic acids research.
[38] P. Sismondi,et al. FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers , 1993, Genes, chromosomes & cancer.
[39] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[40] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[42] F. Bertucci,et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. , 2000, Human molecular genetics.
[43] N Andrieu,et al. Strong association between c-myb and oestrogen-receptor expression in human breast cancer. , 1990, Oncogene.
[44] C. Powell,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Prolactin and Its Receptor in Human Breast Carcinoma* , 2022 .